Okay. And I apologize. It’s probably something on our side, Paul, because you’re doing it, we’re just struggling with your line. So I’m sure it’s on our end. Yeah, we’ve talked about this before. The business is, for us anyway, a modest sized business, which creates a challenge for us relative to some of the bigger competitors. We think, we have a couple of opportunities there. A lot of the work we’re doing inside of our claim environment to strengthen our capability in Specialty Auto, actually helps us inside of the Preferred space. There clearly is a segment of that business and there’s claim population has higher limits and we have a specialized team that works on that. But the lower limits, the metal coverages, certain pieces of that, the strength we’re building in our Specialty Auto actually will provide us some lift and some benefit on that side, which will help us out. We get benefits similarly from the analytics, we get benefits as we’re growing the business overall. Literally just spreading fixed costs for the organization actually helps reduce some of the expense pressure inside of that business. So those are reasons why being part of the portfolio are helping that business. So we see opportunities there. We’ve got a very thoughtful team, who is working on in many ways, what are basic blocking and tackling, pricing, underwriting, agency management capabilities. What I think is important to notice in that business, and one of the things we’re fairly proud of, if you back up 3 years ago, 4 years ago, there was a lot more earnings volatility in that business. We saw a lot of cat volatility. We improved the margins in the business, and then, we used some of that margin improvement to buy an aggregate catastrophe treaty. When you buy that, that immediately takes premium out of the top-line, and it actually puts pressure on the underlying combined ratio, because the premium goes away and underlying combined ratio doesn’t include tax. So that appears to be an underlying combined ratio pressure. All of the benefits we got, we spent that way and it took dramatically reduced the earnings volatility inside of that business. So that is a huge risk reward return benefit to shareholders, and we feel it’s easy to miss it if all you’re looking at is underlying combined ratio, but it’s a big plus inside of the business. So we think, we can continue to march forward. We had a little bit of a challenge inside of that business in the last 12 months. We had rolled out our Prime new business products. It had rolled out, in particular, in Texas and New York, and had a few challenges in the underlying pricing. We generated some growth there and have a little temperature on the loss ratio. We expect the new business penalty to run through there. It was running hotter than it normally should. We have shut off the things that were causing the problem, but it’s got to work its way through the book and it’s got to work its way through renewals. It’s definitely one that’s got us a little irritated internally that it was there. It’s not entirely surprising with the new product, but we’ve seen it, we stopped it, we’re applying the measure – the medication to fix it. But it’s going to take the 12 months that would normally take on a book like that to roll through the renewals. But we’re highly confident with it identified and the new business that was causing the problem stopped, that it will improve.